Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00742872

Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome

Constipation-Predominant Irritable Bowel Syndrome Clinical Trial

Official title:
A Prospective Double-Blind Placebo-Controlled Trial of Mosapride in Patients With Constipation-Predominant Irritable Bowel Syndrome

Clinical Trial Summary

The purpose of this study is to determine whether Mosapride, an agent which acts on serotonin receptors in the gastrointestinal tract, is effective in the treatment of constipation-predominant irritable bowel syndrome (C-IBS).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00742872
Study type Interventional
Source American University of Beirut Medical Center
Contact
Status Terminated
Phase Phase 3
Start date September 2008
Completion date June 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT05164861 - Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations N/A
Withdrawn NCT05321953 - The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation N/A
Not yet recruiting NCT06319729 - A Chinese Herbal Medicine for IBS-C Phase 2
Completed NCT01085643 - Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) N/A
Completed NCT03150212 - Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype N/A
Recruiting NCT05757037 - Laser Acupuncture on Irritable Bowel Syndrome in Females N/A
Completed NCT05392439 - Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome N/A
Not yet recruiting NCT05921383 - Anorectal Manometry of Patients With Constipation Predominant IBS
Recruiting NCT05134584 - Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Phase 4
Terminated NCT03336034 - Assessment of Responsiveness to Treatment by Experience Sampling Method
Not yet recruiting NCT04666155 - MOWOOT Device Treatment for Adults With Chronic Constipation N/A
Not yet recruiting NCT05941650 - To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome N/A
Completed NCT00945334 - Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome N/A
Completed NCT00912301 - Cheno Effect on Transit in Health and IBS-C Phase 2
Terminated NCT00607971 - Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) Phase 3